Evidence map›Paper›PMID 24833936›Full record

ReviewClinical medicine insights. Gastroenterology2012

Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?

Cheryl Durand, Kristine C Willett, Alicia R Desilets

Abstract readReview
In one paragraph

Review in Clinical medicine insights. Gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Diagnostic Challenges ofCanadian journal of gastroenterology & hepatology · 2022
    Article
  5. Article
  6. Pharmacist-structured review of proton pump inhibitor utilisation in primary care: A nonrandomised control study.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Authors Reply.Kidney international reports · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cheryl DurandMassachusetts College of Pharmacy and Health Sciences, Manchester, NH.
Kristine C WillettMassachusetts College of Pharmacy and Health Sciences, Manchester, NH.
Alicia R DesiletsConcord Hospital, Concord, NH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proton pump inhibitors (PPIs) are among the most common classes of medications prescribed. Though they were previously thought of as safe, recent literature has shown risks associated with their use including increased risk for Clostridium difficile infection, pneumonia, and fractures. Due to these risks, it is important to determine if PPIs are being used appropriately. This review evaluates seven studies in hospitalized patients. Additionally, this review evaluates literature pertaining to recently discovered adverse reactions; all studies found PPIs are being overutilized. Findings highlight the importance of evaluating appropriate therapy with these agents and recommending discontinuation if a proper indication does not exist.

Indexed as

PPIproton pump inhibitorutilization

Identifiers

PMID24833936
PMCPMC3987764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.